Letter: Congress Versus Shkreli

Benjamin Brafman writes: I accompanied Martin Shkreli to a congressional hearing on pharmaceutical pricing that he was compelled to attend, despite advance knowledge that he would invoke his Fifth Amendment privilege. Indeed, in my judgment, the only reason for the committee to force Shkreli to appear in person was to try to publicly humiliate him.

Expert Analysis

Special Reports

  • White-Collar Crime

    In this Special Report from the New York Law Journal, brought to you free by Withum: "Jury Charge Issues Loom in Silver, Skelos Appeals," "Defending Parallel Securities and Commodities Actions," "CFTC Enters the Insider Trading Enforcement Arena," "Analyzing the Impact of SEC's Proposed Uniform Fiduciary Standard" and "NYSE Returns to the Regulatory Beat."

  • E-Discovery Special Report

    From the FRCP changes and burgeoning software options, here's a look at what's in store for e-discovery in 2016.

read more

This Week's Summaries

Legal Tweets